Literature DB >> 9430683

Molecular cloning, expression, and characterization of a novel human serine/threonine protein phosphatase, PP7, that is homologous to Drosophila retinal degeneration C gene product (rdgC).

X Huang1, R E Honkanen.   

Abstract

A novel serine/threonine protein phosphatase (PPase) designated PP7 was identified from cDNA produced from human retina RNA. PP7 has a molecular mass of approximately 75 kDa, and the deduced amino acid sequence of PP7 contains a phosphatase catalytic core domain that possesses all of the invariant motifs of the PP1, PP2A, PP2B, PP4, PP5, and PP6 gene family. However, PP7 has unique N- and C-terminal regions and shares < 35% identity with the other known PPases. The unique C-terminal region of PP7 contains multiple Ca2+ binding sites (i.e. EF-hand motifs). This region of PP7 is similar to the Drosophila retinal degeneration C gene product (rdgC), and PP7 and rdgC share 42.1% identity. Unlike the other known PPases, the expression of PP7 is not ubiquitous; PP7 was only detected in retina and retinal-derived Y-79 retinoblastoma cells. Expression of recombinant human PP7 in baculovirus-infected SF21 insect cells produces an active soluble enzyme that is capable of utilizing phosphohistone and p-nitrophenyl phosphate as substrates. The activity of recombinant PP7 is dependent on Mg2+ and is activated by calcium (IC50 approximately equal to 250 microM). PP7 is not affected by calmodulin and is insensitive to inhibition by okadaic acid, microcystin-LR, calyculin A, and cantharidin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9430683     DOI: 10.1074/jbc.273.3.1462

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Increased protein phosphorylation of cytoplasmic dynein results in impaired motor function.

Authors:  M T Runnegar; X Wei; S F Hamm-Alvarez
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

2.  Normal light response, photoreceptor integrity, and rhodopsin dephosphorylation in mice lacking both protein phosphatases with EF hands (PPEF-1 and PPEF-2).

Authors:  P Ramulu; M Kennedy; W H Xiong; J Williams; M Cowan; D Blesh; K W Yau; J B Hurley; J Nathans
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

Review 3.  The role of serine/threonine protein phosphatases in exocytosis.

Authors:  Alistair T R Sim; Monique L Baldwin; John A P Rostas; Jeff Holst; Russell I Ludowyke
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

Review 4.  Protein phosphatases in pancreatic islets.

Authors:  Henrik Ortsäter; Nina Grankvist; Richard E Honkanen; Åke Sjöholm
Journal:  J Endocrinol       Date:  2014-03-28       Impact factor: 4.286

5.  Dopamine D2 receptor relies upon PPM/PP2C protein phosphatases to dephosphorylate huntingtin protein.

Authors:  Sébastien Marion; Nikhil M Urs; Sean M Peterson; Tatyana D Sotnikova; Jean-Martin Beaulieu; Raul R Gainetdinov; Marc G Caron
Journal:  J Biol Chem       Date:  2014-03-11       Impact factor: 5.157

Review 6.  PPEF/PP7 protein Ser/Thr phosphatases.

Authors:  Alexandra V Andreeva; Mikhail A Kutuzov
Journal:  Cell Mol Life Sci       Date:  2009-08-07       Impact factor: 9.261

7.  Deprotonation states of the two active site water molecules regulate the binding of protein phosphatase 5 with its substrate: A molecular dynamics study.

Authors:  Lingyun Wang; Feng Yan
Journal:  Protein Sci       Date:  2017-07-28       Impact factor: 6.725

8.  NHE3 function and phosphorylation are regulated by a calyculin A-sensitive phosphatase.

Authors:  Diane W Dynia; Amy G Steinmetz; Hetal S Kocinsky
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-16

9.  PP7 is a positive regulator of blue light signaling in Arabidopsis.

Authors:  Simon G Møller; Youn-Sung Kim; Tim Kunkel; Nam-Hai Chua
Journal:  Plant Cell       Date:  2003-05       Impact factor: 11.277

10.  Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine.

Authors:  Zhe Ding; Robert B Raffa
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.